Trenbolone Hexahydrobenzylcarbonate represents the dominant large ester based Trenbolone compound on the market. It was first released by the France based Negma Laboratories in the late 1960’s under the trade name Parabolan. This represents the first and only Trenbolone hormone to ever exist in human grade form. Parabolan was prescribed for many years in cases of malnutrition, which will make a lot of sense as we dive into the compound. It was also prescribed to treat osteoporosis in some cases, as well as in the treatment of cachexia.
mg to 20 mg orally in 2 to 4 divided doses
Duration of therapy: 2 to 4 weeks, may be repeated intermittently as indicated.
-Adjunctive therapy to promote weight gain after weight loss following extensive surgery, chronic infections, or severe trauma, and in some patients who without definite pathophysiologic reasons fail to gain or to maintain normal weight
-To offset the protein catabolism associated with prolonged administration of corticosteroids
-For the relief of the bone pain frequently accompanying osteoporosis